Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Primary Surgical Prevention of Breast Cancer-related Lymphedema

Effect of Lymphatic Microsurgical Preventing Healing Approach (LYMPHA) for Primary Surgical Prevention of Breast Cancer-related Lymphedema

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Lymphedema refers to edema caused by insufficient drainage of interstitial fluid through the lymphatic circulation system. It occurs mainly in the upper and lower extremities and causes chronic inflammation, and finally fibrous adipose tissue is replaced. In this study, the'LYMPHA' (Lymphatic microsurgical preventing healing approach) procedure, which connects lymphatic vessels drained from the arm to the side branches of the axillary vein, contributes to the prevention of lymphedema in patients undergoing axillary lymph node dissection for breast cancer. Investigator aim to help patients' quality of life by prospectively analyzing the effects and applying them to clinical practice, reducing the incidence of lymphedema.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Age over 19 years old 2. Patients who are expected to undergo surgery under the diagnosis of breast cancer, and are determined to undergo axillary lymph node dissection before surgery. Who Should NOT Join This Trial: 1. Patients with vascular and lymph-related diseases 2. Patients with a history of surgical treatment or trauma to both arms and axillary 3. Patients with a history of receiving radiation treatment in both arms, chest, and axilla 4. Patients with confirmed systemic metastasis with stage 4 breast cancer 5. Pregnant and lactating patients Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Age over 19 years old 2. Patients who are expected to undergo surgery under the diagnosis of breast cancer, and are determined to undergo axillary lymph node dissection before surgery. Exclusion Criteria: 1. Patients with vascular and lymph-related diseases 2. Patients with a history of surgical treatment or trauma to both arms and axillary 3. Patients with a history of receiving radiation treatment in both arms, chest, and axilla 4. Patients with confirmed systemic metastasis with stage 4 breast cancer 5. Pregnant and lactating patients

Treatments Being Tested

PROCEDURE

LYMPHA

Axillary reverse mapping is performed before surgery, axillary lymph node resection is performed, and 'LYMPHA' (Lymphatic microsurgical preventing healing approach) is performed, and the surgery is terminated. Subsequently, the occurrence of lymphedema is followed up.

PROCEDURE

control

In the control group, axillary lymph node resection is performed and the surgery is terminated without additional procedures. Subsequently, the occurrence of lymphedema is followed up.

Locations (1)

Gangnam Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea